Abstract
Ginsenosides are dammarane-type or triterpenoidal saponins that contribute to the various pharmacological activities of the medicinal herb Panax ginseng. The putative biosynthetic pathway for ginsenoside biosynthesis is known in P. ginseng, as are some of the transcripts and enzyme-encoding genes. However, few genes related to the UDP-glycosyltransferases (UGTs), enzymes that mediate glycosylation processes in final saponin biosynthesis, have been identified. Here, we generated three replicated Illumina RNA-Seq datasets from the adventitious roots of P. ginseng cultivar Cheongsun (CS) after 0, 12, 24, and 48 h of treatment with methyl jasmonate (MeJA). Using the same CS cultivar, metabolomic data were also generated at 0 h and every 12–24 h thereafter until 120 h of MeJA treatment. Differential gene expression, phylogenetic analysis, and metabolic profiling were used to identify candidate UGTs. Eleven candidate UGTs likely to be involved in ginsenoside glycosylation were identified. Eight of these were considered novel UGTs, newly identified in this study, and three were matched to previously characterized UGTs in P. ginseng. Phylogenetic analysis further asserted their association with ginsenoside biosynthesis. Additionally, metabolomic analysis revealed that the newly identified UGTs might be involved in the elongation of glycosyl chains of ginsenosides, especially of protopanaxadiol (PPD)-type ginsenosides.
Introduction
Korean ginseng (Panax ginseng Meyer, Araliaceae) is a traditional medicinal herb that has been widely used in East Asia for thousands of years1. Roots of P. ginseng and their extracts have been reported to exhibit many therapeutic properties, e.g., maintaining immune homeostasis, improving brain function, preventing cancer, and adjusting blood pressure2–4. Some of the pharmacological activities of ginseng have been attributed to Panax-specific ginsenosides, major triterpenoidal saponin constituents of ginseng5. Ginsenosides are classified into three subgroups based on their aglycone backbone structures: dammaranes, oleananes, and ocotillol triterpenes. P. ginseng ginsenosides are mainly of the dammarane-type, which are further classified as protopanaxadiol (PPD; ginsenoside Rb1, Rc, Rd, Rg3, Rh2, etc.) or protopanaxatriol (PPT; Re, Rg1, Rg2, Rh1, etc.), according to the number of hydroxyl groups6.
We previously revealed the putative biosynthetic pathway for dammarane-type ginsenosides7,8. Briefly, dammarenediol II is generated from isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) by condensation and cyclization reactions, and these are successively catalysed by farnesyl diphosphate synthase (FPPS), squalene synthase (SQS), squalene epoxidase (SQE), and dammarenediol II synthase (DDS). The aglycone ginsenoside metabolites PPD and PPT, are biosynthesized from dammarenediol II through hydroxylation by protopanaxadiol synthase (PgPPDS, CYP716A47) and protopanaxatriol synthase (PgPPTS, CYP716A53v2). Glycosylation of PPD and PPT produces a variety of ginsenosides9. The glycosylation of triterpenoidal aglycones is catalysed by UDP-glycosyltransferases (UGTs) that use uridine diphosphate (UDP)-activated sugar molecules as sugar donors10. More than 150 ginsenosides have been identified from Panax spp.6. This diversity is attributed to many unique UGT-encoding genes11–14. However, only a few UGTs have been characterized for their substrate specificity: PgUGT71A27 (UGTPg1; PPD to compound K)15, PgUGT74AE2 (PPD to ginsenoside Rh2 and compound K to ginsenoside F2, respectively), PgUGT94Q2 (ginsenoside Rh2 to Rg3, F2 to Rd, respectively)16, UGTPg101 (PPT to ginsenoside F1, and further to Rg1), and UGTPg100 (PPT to ginsenoside Rh1, and F1 to Rg1)10. Many other UGTs associated with ginsenoside biosynthesis remain unidentified.
Methyl jasmonate (MeJA) is an important cellular regulator in plants, which is involved in seed germination, root growth, fertility, fruit ripening, senescence, and plant defence mechanisms17. MeJA is an effective elicitor of ginsenoside biosynthesis in cultured cells and adventitious roots of P. ginseng18,19. In our previous study, we applied integrated transcriptomics and metabolomics to investigate metabolism in MeJA-treated adventitious roots of various P. ginseng cultivars7. Increased ginsenoside content corresponded with expression levels of candidate genes in the downstream ginsenoside biosynthetic pathway, including SQE and DDS7; however, the dynamic regulatory mechanism for the final accumulation of ginsenoside, catalysed by UGTs, remains unknown.
Our previous study revealed that, of three ginseng cultivars, adventitious roots of the CS cultivar produced the lowest level of ginsenosides and related gene expression. However, treating CS with MeJA dramatically increased the ginsenoside content and corresponding transcription levels of candidate genes7. Therefore, we deduced that CS would be an appropriate cultivar in which to identify putative UGTs associated with ginsenoside biosynthesis in response to MeJA treatment. In this study, we used complementary transcriptomic and metabolomic approaches to investigate the UGT-catalysed biosynthesis of ginsenosides. Expression levels of UGT-related genes, and ginsenoside contents, were analysed in a time-dependent manner using MeJA-treated adventitious roots of P. ginseng, cultivar CS.
Results and Discussion
Identification of candidate UGTs in P. ginseng
Using the most recent version of the P. ginseng annotation available in the Ginseng Genome Database20 (http://ginsengdb.snu.ac.kr/), 226 UGT genes were identified. Differential gene expression (DEG) analysis revealed that 11 of these were up-regulated after treatment with MeJA. Furthermore, using Interpro PROSITE (ID: PS00375), all 11 of these UGT genes encoded plant secondary product glycosyltransferase (PSPG) motifs, which are believed to be involved in binding the UDP moiety to glycosylate plant secondary metabolites21,22. Three of the 11 UGT genes (Pg_S4493.1, Pg_S4157.4, and Pg_S4174.7) matched with the previously characterized P. ginseng UGT-encoding genes KF377585.1 (PgUGT1), KM491309.1 (PgUGT71A27), and JX898529.1 (PgUGT74AE2) (Fig. 1). The remaining eight were considered novel UGT-encoding candidates.
Phylogenetic analysis was then performed with the candidate UGTs and known UGT proteins from other plant species (Fig. 2). Intriguingly, the candidate UGTs could be placed into the same groups as previously characterized UGT proteins from other plant species. UGTs belonging to the UGT74 family in Arabidopsis thaliana23 and P. ginseng24 recognize substrates of glucosinolates and ginsenoside Rh2, respectively. Evidence that members of the UGT74 family are involved in terpenoid biosynthesis has been reported in A. thaliana25 and P. ginseng (PgUGT71A27)15. We identified three new UGT genes (Pg_S4174.7, Pg_S4174.10 and Pg_S2390.5) belonging to the UGT74 family, along with a previously known P. ginseng UGT (PgUGT74A1).
Members of the UGT73 family are involved in saponin glycosylation in Siberian ginseng (Eleuthreococcus senticosus, Araliaceae)26, and other plants such as Barbarea vulgaris, Medicago truncatula, and Glycine max27. Our analysis revealed that the UGT Pg_S2351.7 is related to the UGT73 family, suggesting a role for that UGT in glycosylation in P. ginseng. Similarly, the involvement of UGT94 and UGT91 family members in triterpene biosynthesis was previously found in P. ginseng (PgUGT94B1) and G. max (GmUGT91H4)28. Here, two novel UGT genes (Pg_S6708.3 and Pg_S0804.16) were grouped into the UGT94 family, and one (Pg_S5521.1) was grouped into the UGT91 family. To validate our RNA-Seq data, we randomly selected six genes for reverse-transcriptase quantitative PCR (qPCR) assays (Fig. 3). The resulting expression patterns were consistent with RNA-Seq data, except for one gene, Pg_S4174.10. We assume that this one discrepancy might have occurred because RNA-Seq read mapping is limited by the presence of highly identical paralog (>95% identity) copies of Pg_S4174.10 in P. ginseng.
Ginsenoside profiles in Panax ginseng adventitious roots
Adventitious root tissues from P. ginseng were prepared after 0, 12, 24, 48, 72, 96, and 120 h of MeJA treatment, and ginsenosides in extracts of those tissues were analysed using ultra-performance liquid chromatography–quad time of flight–mass spectrometry (UPLC-QTOF-MS) in triplicate (Fig. 4). Twenty-one major ginsenoside peaks were observed in LC-MS chromatograms. By comparing retention times and characteristic collision-induced dissociation (CID) fragment ions with reference compounds, 12 major ginsenosides (Rg1, Re, Rf, Rg2, Rb1, Rc, Ro, Rb2, Rb3, Rd, Rg3, and F2) were unambiguously identified. Other peaks were tentatively assigned by comparing their empirical molecular formulae, CID fragmentation patterns, and relative retention times, with those of previously published data (Supplementary Table 1). The analytical method used in this study was similar to that we used previously7, with some modifications to characterize a greater number of ginsenosides in a metabolomic profile. In particular, the peaks of two major ginsenosides, Re and Rg1, could be separated within a chromatogram.
Base peak ion (BPI) chromatograms showed that the levels of most ginsenosides were dramatically increased following MeJA treatment, but some – Rg1 (1), Re (2), and Ro (8) –showed relatively constant amounts. Intensities of chromatographic peaks at tR 3–5 min were also significantly increased; however, these metabolites were not expected to be ginsenosides (expected molecular formula were C18H30O8 and C19H32O10) although they could not be identified precisely. For more detailed analysis of ginsenoside profiles, our LC-MS dataset was processed into a peak table including 156 ion markers using Mzmine 2 software29. Principle component analysis (PCA) was performed on the processed ginsenoside profile to visualize time-dependent metabolic differences. In the PCA score plot, it is easy to recognize the ginsenoside accumulation pattern by increasing principle component 1 (PC1) (Fig. 5A). Between 0 and 120 h of MeJA elicitation, the PC1 value showed a constant increase and accounted for 75.2% of the total variance in the dataset. The PCA loading plot indicates that most ginsenosides correlate positively with PC1, implying that the levels of almost every ginsenoside increased after MeJA elicitation. The ginsenosides Rb1 (5), Rc (7), Rb2 (10), and Rd (14), and malonyl ginsenosides Rb1 (6) and Rd (15) showed especially high positive correlations with PC1, suggesting that biosynthesis of these ginsenosides is significantly induced by MeJA (Fig. 5B).
Time-dependent accumulation patterns of the major ginsenosides were compared based on the ion intensity of their LC-MS profiles. Fold-changed relative abundance according to time after MeJA treatment was calculated using the Mzmine peak ion table (Fig. 6). As shown in Fig. 6, and as also found by Oh et al., the amounts of PPT-type and oleanane-type ginsenosides were not affected by MeJA treatment30, while the levels of PPD-type ginsenosides significantly increased with MeJA treatment and most PPD-type ginsenosides started to accumulate after 48 h. Our previous study suggested that PPD-type ginsenosides are involved in defence mechanisms against biotic stresses, while PPT-types are involved in mechanisms against abiotic stresses30. The ginsenosides Rg3, Rd, and Rb3 showed the most dramatic accumulation, with 106.3, 43.0, and 32.2-fold increases, respectively, after 120 h. Contents of the ginsenosides Rb1, Rb2, and Rc also significantly increased, with 15.2, 14.2, and 17.9-fold changes, respectively. The accumulation patterns of the ginsenoside F2, compounds Mc1 and O, and gypenoside XVII suggested that they became saturated after 96 h. Malonylated ginsenosides, a group of derivatives that are compartmentalized in the vacuole31, also increased in content, but these changes were relatively small compared with non-malonylated ginsenosides.
A putative biosynthetic pathway and biological roles of ginsenosides
Figure 7 shows the possible biosynthetic pathways of the PPD-type ginsenosides that significantly accumulated after MeJA treatment. These pathways are proposed based on their sugar moiety sequences. Of the compounds identified, several have two glucose residues at the C3-OH position, and there are two possible pathways for the biosynthesis of ginsenosides Rb1, Rb2, Rb3 and Rc (see red and blue lines in Fig. 7). The red pathway follows the route from ginsenoside Rg3 to ginsenosides Rb1, Rb2, Rb3, and Rc through ginsenoside Rd. Several different UGTs might be involved in this step by adding different glucose moieties, such as Glc, Xyl, Ara(p) and Ara(f). The blue pathway uses different substrates, but the reaction is the same: adding a glucose residue to 3-O-glucoside. In MeJA-treated adventitious roots of P. ginseng, the fold-changes of ginsenosides Rb1, Rb2, Rb3, and Rc show similar patterns as in Fig. 6, implying that these compounds are produced by a single UGT, or are co-controlled by very similar UGTs. Therefore, we suggest that the biosynthesis of ginsenosides Rb1, Rb2, Rb3, and Rc follows the blue pathway shown in Fig. 7.
Malonylation is a common form of plant metabolism used to store toxic materials separately in vacuoles32. The fact that ginsenosides undergo malonylation therefore provides evidence for the role of ginsenosides in defence. Malonylated ginsenosides significantly elicited by MeJA treatment in our study were Rb1, Rb2, Rb3, Rc, Rd, and gypenoside XVII. We therefore suggest that these ginsenosides are the metabolites related to plant defence in P. ginseng, and propose that the 11 UGTs – including eight novel UGTs – identified in this study may contribute to the glycosylation of these ginsenosides.
Conclusion
We investigated time-dependent changes in UGT-related gene expression and ginsenoside content of MeJA-treated adventitious roots of the P. ginseng cultivar CS, which was previously shown to markedly increase ginsenoside biosynthesis upon treatment with MeJA. Transcriptomic analysis identified 11 candidate UGTs, including eight novel and three previously characterized UGTs. Metabolic profiling and phylogenetic analysis revealed that these candidate UGTs are strongly associated with ginsenoside biosynthesis. Furthermore, these newly identified UGTs might be related to steps involving the elongation of ginsenoside glycosyl chains, especially in PPD-type ginsenosides. Further functional characterization studies will elucidate the specific substrates of these UGTs in P. ginseng.
Materials and Methods
Plant materials
Adventitious roots of P. ginseng (CS cultivar) were cultured as previously described33 and amplified in bioreactors containing 1 L Schenk and Hildebrandt liquid medium supplemented with 3 mg/L indole-3-butyric acid and 5% sucrose. Three grams of these fresh proliferated roots was transferred into 250-mL flasks containing the same medium supplemented with 200 µM MeJA and cultured at 23 ± 1 °C on a rotary shaker at 100 rpm under constant dark conditions. We selected 21 flasks containing healthy growing adventitious roots and harvested these with three replications for each condition: 0, 12, 24, 48, 72, 96, and 120 h after initiation of MeJA treatment.
Chemicals and reagents
Standard references of 12 ginsenosides were purchased from Chengdu Biopurify Phytochemicals Co., Ltd. (Chengdu, China; Rb1, Rb2, Rf, Rg2, Rg3, Ro, and F2) and Chromadex (Irvine, CA, USA; Rb3, Rc, Rd, and Re), or were provided by the Korean Food and Drug Administration (Rg1). Chemicals for tissue culture were purchased from Duchefa (Haarlem, The Netherlands), and high-performance liquid chromatography (HPLC) grade solvents were purchased from Avantor Performance Materials Inc. (Center Valley, PA, USA). All other chemicals were purchased from Sigma–Aldrich (St. Louis, MO, United States).
RNA isolation and transcriptome sequencing using the Illumina platform
Total RNA was isolated from MeJA-treated adventitious roots after 12, 24 and 48 h using the RNeasy Plant Kit (QIAGEN, Germany) according to the manufacturer’s instructions. After examining its quality and quantity using a bioanalyzer (Agilent Technologies, USA), about 2 μg total RNA was used to independently construct RNA-Seq libraries with an insert size of 300 bp using the Illumina TruSeq RNA Sample Preparation Kit according to the manufacturer’s instructions. Pooled libraries were sequenced with a paired-end read length of 150 bp using the Illumina NextSeq 500 platform at LabGenomics Co. (Seongnam, Korea). Raw reads were deposited into the National Center for Biotechnology Information Sequencing Read Archive. Accession numbers are provided in Table 1. Prior to differential gene expression analysis, reads containing bacterial contaminants were removed by mapping against available bacterial genomes using BWA34. Adaptor contamination was then removed using the NGS QC Toolkit (v2.3.3)35.
Table 1.
CS adventitious roots | Raw data | Filtered data | SRA accession no. | ||
---|---|---|---|---|---|
Total no. of reads | Length (bp) | Total no. of reads | Length (bp) | ||
CS, replicate 1* | 16,731,664 | 2,321,621,040 | 15,291,398 | 2,115,447,628 | SRR2132332 |
CS, replicate 2* | 14,306,820 | 1,977,938,763 | 12,831,592 | 1,766,225,247 | SRR1688723 |
CS, replicate 3* | 14,801,822 | 2,056,937,756 | 13,407,302 | 1,857,154,376 | SRR2132333 |
CS, 12 h replicate 1 | 13,820,382 | 1,893,236,025 | 12,221,130 | 1,665,343,695 | SRR6384120 |
CS, 12 h replicate 2 | 13,549,482 | 1,889,923,163 | 11,912,380 | 1,655,061,269 | SRR6384121 |
CS, 12 h replicate 3 | 14,884,004 | 1,951,092,722 | 12,996,188 | 1,689,391,983 | SRR6384122 |
CS, 24 h replicate 1 | 13,708,904 | 1,903,958,122 | 12,125,782 | 1,677,279,963 | SRR6384123 |
CS, 24 h replicate 2 | 14,492,432 | 2,015,422,717 | 12,732,674 | 1,762,648,809 | SRR6384124 |
CS, 24 h replicate 3 | 13,891,838 | 1,927,722,530 | 12,173,452 | 1,681,509,097 | SRR6384125 |
CS, 48 h replicate 1 | 11,055,530 | 1,531,553,431 | 9,669,218 | 1,333,220,591 | SRR6384126 |
CS, 48 h replicate 2 | 14,083,014 | 1,945,787,757 | 12,425,406 | 1,709,114,504 | SRR6384127 |
CS, 48 h replicate 3 | 15,591,720 | 2,160,145,356 | 13,525,934 | 1,864,372,366 | SRR6384128 |
Total | 170,917,612 | 23,575,339,382 | 151,312,456 | 20,776,769,528 |
*Replicated transcriptomes of CS obtained from a previous report38.
Identification of UGTs in P. ginseng and differential gene expression analysis
The current version of the ginseng gene set (IPGA_v1.1) was retrieved from the Ginseng Genome Database20 (https://ginsengdb.snu.ac.kr). Protein domains and motifs of UGT genes in P. ginseng were identified using InterProScan36. Trimmed, high-quality RNA-Seq reads were mapped to the ginseng gene set to calculate fragments per kilobase per million (FPKM) using RSEM37. The bioconductor package edgeR38 was used to identify differentially expressed genes in MeJA-treated samples. Genes exhibiting changes greater than two-fold with a significant false discovery rate (FDR) of 0.001 were considered differentially expressed.
Quantitative RT-PCR assay
Total RNA was isolated from the adventitious roots of P. ginseng cultivar CS treated with MeJA using the RNeasy Plant Kit (QIAGEN, Germany) according to the manufacturer’s protocol. RNA quality and quantity was examined using formaldehyde agarose gel electrophoresis. cDNA was synthesized using 1 µg of RNA (Invitrogen, USA), and the cDNA was diluted to 1/10 for use in quantitative polymerase chain reaction (qPCR). qPCR was performed using SYBR Green Power PCR Master Mix (Applied Biosystems, Foster City, CA) in the Roche Lightcycler 480 Realtime PCR system (Roche, Indianapolis, IN). The thermal cycling conditions for PCR were: 95 °C for 5 min, 30 cycles at 95 °C for 5 s, 60 °C for 30 s and 72 °C for 30 s, followed by 72 °C for 5 min. qPCR was carried out in duplicate for each sample. The qPCR primers used in this study are listed in Supplementary Table 2.
Ginsenoside analysis using LC–MS
Twenty milligrams of freeze-dried sample powder was sonicated with 1 mL of 70% ethanol for 90 min at room temperature. Extracts were centrifuged at 17,000 × g for 3 min, then 500 μL of each supernatant was dried using nitrogen gas and resuspended in 1 mL 50% methanol. Prepared samples were analyzed using a Waters ACQUITY ultra-performance liquid chromatography (UPLC) system (Waters Co., Milford, MA, USA) coupled with a Waters Xevo G2 quad time-of-flight (QTOF) mass spectrometer (Waters MS Technologies, Manchester, UK), which was equipped with an electrospray interface (ESI). Separation was performed on an ACQUITY UPLC BEH C18 (100 mm × 2.1 mm, 1.7 μm, Waters Co.) column. The mobile phase consisted of 0.1% formic acid in water (A) and acetonitrile (B) with the following gradient condition: 20% B (0–9 min); 20–30% B (9–14 min); 30% B (14–17 min); 30–32% B (17–21 min); 32–42.5% B (21–26 min); 42.5–90% B (26–30 min). The flow rate of the mobile phase was 0.3 mL/min, and the column temperature was maintained at 25 °C. Analyses of the samples (1.0 μL injected into the partial loop in needle overfill mode) were performed in negative ion mode in the 100–1500 Da range, with acquisition times of 0.2 s in centroid mode. ESI conditions were set as follows: capillary voltage 3.5 kV, con voltage 45 V, source temperature 120 °C, desolvation temperature 300 °C, cone gas flow 50 L/h, and desolvation gas flow 800 L/h. High-purity nitrogen was used as the nebulizer and auxiliary gas, and argon was used as the collision gas. The mass spectrometer was calibrated using sodium formate over a range of 100–1500 Da; leucine enkephalin (m/z 554.2615 [M –H ]−) was used as the lockmass to ensure mass accuracy and reproducibility. To identify ginsenosides, collision-induced dissociation (CID) data were recorded using MSE methodology39. Low collision energy to detect precursor ions was set to 4 eV, and the high collision energy for fragmentation was set to 40–45 eV.
LC–MS Data processing and multivariate analysis
Mass spectrometry (MS) ion markers were extracted from liquid chromatography–mass spectrometry (LC-MS) raw data using Mzmine2 2.30 software40. Mass ion detection was performed with the noise level set to 2000, and based on the detected mass list, peak lists were built with criteria as follows: minimum time span of 0.02 min, minimum height of 3000, and m/z tolerance of 0.006 Da (or 10.0 ppm). Chromatographic deconvolution was achieved using the baseline cut-off algorithm (minimum peak height of 3000, peak duration range of 0.02–0.30 min, and baseline level of 1000). Chromatograms were de-isotoped using the isotopic peaks grouper algorithm with an m/z tolerance of 0.006 Da (or 10.0 ppm) and a tR tolerance of 0.1 min. Peak lists for samples were aligned together using the join aligner module (m/z tolerance at 0.006 Da or 20 ppm, absolute tR tolerance at 0.3 min, weight for m/z of 70, and weight for tR of 30), and the aligned peak list was eventually gap-filled with the peak finder module (intensity tolerance at 50%, m/z tolerance at 0.006 Da or 10.0 ppm, and absolute tR tolerance of 0.2 min). Peaks from MS contaminants were identified by blank injection, and duplicate peaks were manually removed from the aligned and gap-filled peak list. Principal component analysis (PCA) was performed using SIMCA 13.0 software (Umetrics, Umeå, Sweden), with Pareto scaling of data.
Electronic supplementary material
Acknowledgements
This work was carried out with the support of the Next-Generation BioGreen21 Program for Agriculture and Technology Development, Rural Development Administration, Republic of Korea (Grant Number PJ01311901). This article is dedicated to the memory of our esteemed colleague Prof. Sang Hyun Sung, a good friend, inspiring mentor, and talented scientist who prematurely passed away on July 24th, 2018.
Author Contributions
T.J.Y., M.J. and S.H.S. conceived and designed the study. V.B.N., Y.S.L. and H.S.P. prepared MeJA-treated samples and RNA-Seq libraries. M.J. did all bioinformatics analysis. Y.S. and H.J.K. performed qRT-PCR experiments. K.B.K., I.Y.C., D.H.K., Y.J.C., B.R. and D.Y.L. designed and analysed metabolic profiling data. K.B.K., M.J., T.J.Y., S.H.S. and Y.S.L. wrote the manuscript. All authors have read and approved the final manuscript.
Competing Interests
The authors declare no competing interests.
Footnotes
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Kyo Bin Kang, Email: kbinkang@gmail.com.
Tae-Jin Yang, Email: tjyang@snu.ac.kr.
Electronic supplementary material
Supplementary information accompanies this paper at 10.1038/s41598-018-30262-7.
References
- 1.Dharmananda S. The nature of ginseng: traditional use, modern research and the question of dosage. Herb. Gram. 2002;54:343–351. [Google Scholar]
- 2.Vogler BK, Pittler MH, Ernst E. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol. 1999;55:567–575. doi: 10.1007/s002280050674. [DOI] [PubMed] [Google Scholar]
- 3.Kang S, Min H. Ginseng, the ‘Immunity Boost’: The Effects of Panax ginseng on Immune System. J Ginseng Res. 2012;36:354–368. doi: 10.5142/jgr.2012.36.4.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Coleman CI, Hebert JH, Reddy P. The effects of Panax ginseng on quality of life. J Clin Pharm Ther. 2003;28:5–15. doi: 10.1046/j.1365-2710.2003.00467.x. [DOI] [PubMed] [Google Scholar]
- 5.Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol. 1999;58:1685–1693. doi: 10.1016/S0006-2952(99)00212-9. [DOI] [PubMed] [Google Scholar]
- 6.Christensen LP. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res. 2009;55:1–99. doi: 10.1016/S1043-4526(08)00401-4. [DOI] [PubMed] [Google Scholar]
- 7.Lee, Y. S. et al. Integrated Transcriptomic and Metabolomic Analysis of Five Panax ginseng Cultivars Reveals the Dynamics of Ginsenoside Biosynthesis. Front Plant Sci8 (2017). [DOI] [PMC free article] [PubMed]
- 8.Kim, N. H. et al. Genome and evolution of the shade-requiring medicinal herb Panax ginseng. Plant Biotechnol J, 10.1111/pbi.12926 (2018). [DOI] [PMC free article] [PubMed]
- 9.Kim YJ, Lee OR, Oh JY, Jang MG, Yang DC. Functional analysis of 3-hydroxy-3-methylglutaryl coenzyme a reductase encoding genes in triterpene saponin-producing ginseng. Plant Physiol. 2014;165:373–387. doi: 10.1104/pp.113.222596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wei W, et al. Characterization of Panax ginseng UDP-Glycosyltransferases Catalyzing Protopanaxatriol and Biosyntheses of Bioactive Ginsenosides F1 and Rh1 in Metabolically Engineered Yeasts. Mol Plant. 2015;8:1412–1424. doi: 10.1016/j.molp.2015.05.010. [DOI] [PubMed] [Google Scholar]
- 11.Sun, C. et al. De novo sequencing and analysis of the American ginseng root transcriptome using a GS FLX Titanium platform to discover putative genes involved in ginsenoside biosynthesis. BMC Genomics11 (2010). [DOI] [PMC free article] [PubMed]
- 12.Chen S, et al. 454 EST analysis detects genes putatively involved in ginsenoside biosynthesis in Panax ginseng. Plant Cell Rep. 2011;30:1593–1601. doi: 10.1007/s00299-011-1070-6. [DOI] [PubMed] [Google Scholar]
- 13.Luo, H. M. et al. Analysis of the transcriptome of Panax notoginseng root uncovers putative triterpene saponin-biosynthetic genes and genetic markers. BMC Genomics12 (2011). [DOI] [PMC free article] [PubMed]
- 14.Li, C. F. et al. Transcriptome analysis reveals ginsenosides biosynthetic genes, microRNAs and simple sequence repeats in Panax ginseng C. A. Meyer. BMC Genomics14 (2013). [DOI] [PMC free article] [PubMed]
- 15.Yan X, et al. Production of bioactive ginsenoside compound K in metabolically engineered yeast. Cell Res. 2014;24:770–773. doi: 10.1038/cr.2014.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Jung SC, et al. Two Ginseng UDP-Glycosyltransferases Synthesize Ginsenoside Rg(3) and Rd. Plant Cell Physiol. 2014;55:2177–2188. doi: 10.1093/pcp/pcu147. [DOI] [PubMed] [Google Scholar]
- 17.Cheong JJ, Choi YD. Methyl jasmonate as a vital substance in plants. Trends Genet. 2003;19:409–413. doi: 10.1016/S0168-9525(03)00138-0. [DOI] [PubMed] [Google Scholar]
- 18.Kim YS, Hahn EJ, Murthy HN, Paek KY. Adventitious root growth and ginsenoside accumulation in Panax ginseng cultures as affected by methyl jasmonate. Biotechnol Lett. 2004;26:1619–1622. doi: 10.1007/s10529-004-3183-2. [DOI] [PubMed] [Google Scholar]
- 19.Thanh NT, Murthy HN, Yu KW, Hahn EJ, Paek KY. Methyl jasmonate elicitation enhanced synthesis of ginsenoside by cell suspension cultures of Panax ginseng in 5-I balloon type bubble bioreactors. Appl Microbiol Biot. 2005;67:197–201. doi: 10.1007/s00253-004-1759-3. [DOI] [PubMed] [Google Scholar]
- 20.Jayakodi, M. et al. Ginseng Genome Database: an open-access platform for genomics of Panax ginseng. BMC Plant Biol18 (2018). [DOI] [PMC free article] [PubMed]
- 21.Gachon CMM, Langlois-Meurinne M, Saindrenan P. Plant secondary metabolism glycosyltransferases: the emerging functional analysis. Trends Plant Sci. 2005;10:542–549. doi: 10.1016/j.tplants.2005.09.007. [DOI] [PubMed] [Google Scholar]
- 22.Vogt T, Jones P. Glycosyltransferases in plant natural product synthesis: characterization of a supergene family. Trends Plant Sci. 2000;5:380–386. doi: 10.1016/S1360-1385(00)01720-9. [DOI] [PubMed] [Google Scholar]
- 23.Grubb CD, et al. Comparative analysis of Arabidopsis UGT74 glucosyltransferases reveals a special role of UGT74C1 in glucosinolate biosynthesis. Plant J. 2014;79:92–105. doi: 10.1111/tpj.12541. [DOI] [PubMed] [Google Scholar]
- 24.Kim, S. C. et al. UDP-glycosyltransferase derived from ginseng and use thereof (2017).
- 25.Caputi L, Malnoy M, Goremykin V, Nikiforova S, Martens S. A genome-wide phylogenetic reconstruction of family 1 UDP-glycosyltransferases revealed the expansion of the family during the adaptation of plants to life on land. Plant J. 2012;69:1030–1042. doi: 10.1111/j.1365-313X.2011.04853.x. [DOI] [PubMed] [Google Scholar]
- 26.Hwang, H. S., Lee, H. & Choi, Y. E. Transcriptomic analysis of Siberian ginseng (Eleutherococcus senticosus) to discover genes involved in saponin biosynthesis. BMC Genomics16 (2015). [DOI] [PMC free article] [PubMed]
- 27.Thimmappa R, Geisler K, Louveau T, O’Maille P, Osbourn A. Triterpene Biosynthesis in Plants. Annual Review of Plant Biology, Vol 65. 2014;65:225–257. doi: 10.1146/annurev-arplant-050312-120229. [DOI] [PubMed] [Google Scholar]
- 28.Shibuya M, Nishimura K, Yasuyama N, Ebizuka Y. Identification and characterization of glycosyltransferases involved in the biosynthesis of soyasaponin I in Glycine max. FEBS Lett. 2010;584:2258–64. doi: 10.1016/j.febslet.2010.03.037. [DOI] [PubMed] [Google Scholar]
- 29.Pluskal, T., Castillo, S., Villar-Briones, A. & Oresic, M. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics11 (2010). [DOI] [PMC free article] [PubMed]
- 30.Oh JY, et al. Investigation of ginsenosides in different tissues after elicitor treatment in Panax ginseng. J Ginseng Res. 2014;38:270–277. doi: 10.1016/j.jgr.2014.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kochkin DV, et al. Malonyl-ginsenoside content of a cell-suspension culture of Panax japonicus var. repens. Phytochemistry. 2013;93:18–26. doi: 10.1016/j.phytochem.2013.03.021. [DOI] [PubMed] [Google Scholar]
- 32.Taguchi G, et al. Malonylation is a key reaction in the metabolism of xenobiotic phenolic glucosides in Arabidopsis and tobacco. Plant J. 2010;63:1031–1041. doi: 10.1111/j.1365-313X.2010.04298.x. [DOI] [PubMed] [Google Scholar]
- 33.Jayakodi M, et al. Transcriptome profiling and comparative analysis of Panax ginseng adventitious roots. J Ginseng Res. 2014;38:278–288. doi: 10.1016/j.jgr.2014.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–1760. doi: 10.1093/bioinformatics/btp324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Patel, R. K. & Jain, M. NGS QC Toolkit: A Toolkit for Quality Control of Next Generation Sequencing Data. Plos One7 (2012). [DOI] [PMC free article] [PubMed]
- 36.Jones P, et al. InterProScan 5: genome-scale protein function classification. Bioinformatics. 2014;30:1236–1240. doi: 10.1093/bioinformatics/btu031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics12 (2011). [DOI] [PMC free article] [PubMed]
- 38.Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–140. doi: 10.1093/bioinformatics/btp616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Plumb RS, et al. UPLC/MSE; a new approach for generating molecular fragment information for biomarker structure elucidation. Rapid Commun Mass Sp. 2006;20:1989–1994. doi: 10.1002/rcm.2550. [DOI] [PubMed] [Google Scholar]
- 40.Lee YS, et al. Comparative analysis of the transcriptomes and primary metabolite profiles of adventitious roots of five Panax ginseng cultivars. J Ginseng Res. 2017;41:60–68. doi: 10.1016/j.jgr.2015.12.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.